A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aiping Zhou
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Principal Investigator - Chunmei Bai
Peking Union Medical College Hospital
Principal Investigator - Haijiao Yan
The First People's Hospital of Changzhou
Principal Investigator - Haiping Jiang
Zhejiang University
Principal Investigator - Hongming Pan
Sir Run Run Shaw Hospital
Principal Investigator - Jieer Ying
Zhejiang Cancer Hospital
Principal Investigator - Jin Li
Shanghai East Hospital
Principal Investigator - Jing Dai
Zhongnan Hospital
Principal Investigator - Jun Zhou
Shanghai Gaobo Cancer Hospital
Principal Investigator - Lixin Wan
Nanyang Central Hospital
Principal Investigator - Mingzhu Huang
Fudan University
Principal Investigator - Ning Wu
Shanghai Pudong New District Gongli Hospital
Principal Investigator - Rushen Zhao
Zibo Municipal Hospital
Principal Investigator - Xianglin Yuan
Tongji Hospital
Principal Investigator - Yabin Xia
First Affiliated Hospital of Wannan Medical College
Principal Investigator - Yiping Mou
Zhejiang Provincial People's Hospital
Principal Investigator - Youwei Zhang
Xuzhou Central Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Shanghai East Hospital
Shanghai, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Jul 2023
- Primary completion
- 1 Jul 2026
- Completion
- 1 Jul 2028
- Last update posted
- 12 Sept 2025
- Registered enrollment
- 276
- Registry id
- NCT05934331
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.